Low price of generics to be a triggering factor for the expansion of the market

Share on facebook
Share on twitter
Share on linkedin
Generic Drugs Market By Type (Biosimilars, Simple Generic And Super Generic) By Therapeutic Drugs (Cardiovascular Products, Anti-infective Products

Market Overview:

The world generic drug market accounted for around USD 200.20 billion in 2015 and is estimated to reach around USD 380.60 billion by 2021, growing at a CAGR of around 10.8 % between 2016 and 2021. Generic drugs are bioequivalent to branded medicines in quality, dosage type, strength, intended employment and route of administration. After the expiry of the patent, the same branded drug can be derived and made by any other maker at a reasonable price.

Market drivers and restraints:

The low price of generics, as a substitute to branded medicine, is the major factor triggering the world generic drugs market expansion. The employment of RPA to make sure regulatory and standards compliance is one of the foremost branded generics market trends which will gain traction in upcoming years. Business method automation technologies such as RPA are extensively being adopted by pharmaceutical industries to handle high volume tasks in R&D and making. RPA technology includes software that logs into applications, enters information, calculates and finishes the required tasks, and logs out. This helps in maintaining compliance with laws and standards, finishing processes at a faster speed, and reducing prices.

To know more, click on the link below:


Report segmented as:

By type:

simple generic
super generic
By application:

cardiovascular products
anti-infective drugs
anti-arthritis drugs
central nervous system drugs
anti-cancer drugs
respiratory products
Geographical analysis:

On the basis of geography, the market has been segregated into North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa. North America is leading the generic drug market because of the high demand and rising the prevalence of chronic diseases. Asia-Pacific is estimatedto show noticeable growth throughout the forecast period. In the Asia Pacific, India and China are dominating countries in the generic drug market.

Important market players:

The pharmaceutical companies profiled in the report are Ranbaxy Laboratories, Ltd, Actavis, Mylan, Inc., Teva Pharmaceutical Industries, Ltd., Dr. Reddy’s Laboratories, Sandoz International GmbH, Apotex, Inc., Par Pharmaceutical, Inc., Hospira, Inc., Watson Pharmaceuticals, Ltd. and others.

View a sample and decide:


The Scope of the report:

This report offers the current product and services market evaluation and the future estimation of the market. It helps us understand the market better through size anticipation and CAGR calculation to estimate the next market. It has a broader segmentation for better understanding of the enterprising of the market at a low level by segregating the market into smaller sectors.

Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

About Us:

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:

Abhishek Shukla

Sales Manager at Market Data Forecast

Email: abhishek@marketdataforecast.com

Tel: +1-888-702-9626

Website: https://www.marketdataforecast.com/